Woodline Partners’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.72M Hold
201,667
0.03% 603
2025
Q4
$6.97M Hold
201,667
0.03% 550
2025
Q3
$5.49M Sell
201,667
-24,723
-11% -$598K 0.03% 543
2025
Q2
$4.76M Sell
226,390
-88,982
-28% -$1.71M 0.03% 571
2025
Q1
$5.17M Sell
315,372
-275,325
-47% -$5.87M 0.03% 500
2024
Q4
$15.2M Buy
590,697
+1,943
+0.3% +$55K 0.1% 263
2024
Q3
$18.7M Buy
588,754
+132,301
+29% +$5.02M 0.16% 202
2024
Q2
$16M Buy
456,453
+30,451
+7% +$1.21M 0.15% 198
2024
Q1
$18.7M Buy
426,002
+11,943
+3% +$514K 0.17% 180
2023
Q4
$14.7M Buy
414,059
+173,631
+72% +$5.18M 0.16% 186
2023
Q3
$6.49M Buy
240,428
+63,404
+36% +$1.61M 0.08% 278
2023
Q2
$4.16M Buy
+177,024
New +$3.64M 0.05% 318
2022
Q1
Sell
-498,187
Closed -$11.8M 766
2021
Q4
$11.8M Buy
498,187
+353,808
+245% +$8.22M 0.17% 166
2021
Q3
$3.68M Sell
144,379
-92,316
-39% -$2.16M 0.06% 302
2021
Q2
$4.97M Sell
236,695
-53,254
-18% -$1.09M 0.09% 218
2021
Q1
$6.81M Buy
+289,949
New +$5.6M 0.15% 166

Other funds holding IDYA

Woodline Partners's IDYA Position: Q1 2026 in Review

Woodline Partners held its IDEAYA Biosciences (IDYA) position steady in Q1 2026 at 201,667 shares worth $6.72M. The position accounts for 0.03% of the portfolio, ranked #603.

Woodline Partners first reported a position in IDYA in Q1 2021 and has held it in 16 quarters since. The position peaked at $18.7M in Q1 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Woodline Partners held 201,667 shares of IDEAYA Biosciences worth $6.72M as of Q1 2026.
  • Woodline Partners left its IDEAYA Biosciences share count unchanged in Q1 2026.
  • IDEAYA Biosciences made up 0.03% of Woodline Partners's portfolio in Q1 2026, its #603 holding.
  • Woodline Partners first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 16 quarters since.
  • Woodline Partners's IDEAYA Biosciences position peaked at $18.7M in Q1 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.